Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Treatment of Types I, II and III Pleuropulmonary Blastoma (PPB)

NCT06647953 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT06647953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06647953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Treatment of Types I, II and III Pleuropulmonary Blastoma (PPB)
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Recruiting
Start date
March 21, 2025
Completion date
March 31, 2029
Enrollment
110 (estimated)
Sites
87

Conditions

As the registry lists them; a condition with its own page is linked.

pleuropulmonary blastoma